An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Clovis Oncology, Inc. (NASDAQ: CLVS) will release its second quarter 2022 financial results and provide updates on clinical development on August 8, 2022, before US markets open. A conference call featuring senior management will take place at 6:30am ET to discuss the results and outlook in detail. Participants can join via dial-in or through the company's website, where a replay will be available for 30 days. Clovis focuses on innovative anti-cancer agents and collaborates on diagnostic tools to target specific cancer populations.
Positive
None.
Negative
None.
BOULDER, Colo.--(BUSINESS WIRE)--
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2022 financial results and provide an update on its clinical development programs and regulatory and business outlook on Monday, August 8, 2022, before the open of the US financial markets. Clovis’ senior management will host a conference call and live audio webcast at 6:30am ET to discuss Clovis’ results and business outlook in greater detail.
The conference call will be simultaneously webcast on the Clovis Oncology website www.clovisoncology.com, and a replay of the webcast will be available for 30 days.
Dial-in numbers for the conference call are as follows: US participants 888.440.4615 International participants 646.960.0682, conference ID: 2259685.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the US, Europe, and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops with partners diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com for more information, including additional office locations in the US and Europe.
When will Clovis Oncology announce its second quarter 2022 financial results?
Clovis Oncology will announce its second quarter 2022 financial results on August 8, 2022, before US markets open.
What time is the Clovis Oncology conference call to discuss financial results?
The conference call will take place at 6:30am ET on August 8, 2022.
How can I access the Clovis Oncology conference call?
You can access the conference call by dialing 888.440.4615 for US participants or 646.960.0682 for international participants, using conference ID 2259685.
Where can I find more information about Clovis Oncology?
More information about Clovis Oncology can be found on their website at www.clovisoncology.com.
